alexa Clinical Proteomics For Biomarker Discovery And Verification Of Bladder Cancer
ISSN: 2157-7064

Journal of Chromatography & Separation Techniques
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

4th World Congress on MASS SPECTROMETRY
June 19-21, 2017 London, UK

Yi-Ting Chen
Chang Gung University, Taiwan
ScientificTracks Abstracts: J Chromatogr Sep Tech
DOI: 10.4172/2157-7064-C1-025
Abstract
Bladder cancer is potentially lethal and is a costliest urological malignancy to manage. Base on the morbidity and mortality, diagnosis and treatment of the cancer are important issues for the better clinical practice. To discover potential biomarkers of bladder cancer, we employed a strategy combining isotopic labeling and LC-MS/MS analysis to profile proteomic changes in secretome, clinical urine, urine microparticles, and fresh-frozen bladder tumor specimens. Seven differentially-expressed proteins have been selected as potential biomarker candidates for verification by immuno-assays or multiple-reaction-monitoring MS in more clinical specimens. Overall, the urinary concentrations of the classical plasma proteins or acute phase proteins show the best AUC values for discrimination between age-matched control and bladder cancer patients. Proteomic analysis of urinary microparticles reveals strong association of TACSTD2 with bladder cancer. TAGLN2 shows the most significant overexpression in bladder cancer tissues and might be a useful molecular tumor marker for evaluating bladder cancer lymph node metastasis. Urinary TAGLN2 also represents a potential biomarker for non-invasive screening of bladder cancer. Our findings highlight the value of integration of multiple clinical proteomes in providing valuable information for protein origin, specificity and application for future validation studies of potential biomarkers in bladder carcinoma.
Biography

Yi-Ting Chen received her Ph.D. degree in Department of Chemistry from the National Tsing Hua University, Taiwan. From September 2007, she worked at Molecular Medicine Research Center of Chang Gung University (CGU) with focusing on urinary protein biomarker discovery. Being an assistant professor in Department of Biomedical Sciences of CGU since 2013, Dr. Chen’s research interests focus on proteomics, metabolomics and systems biology of urological diseases and advanced method development for detection of disease-associated biomolecules, primarily based on mass spectrometry. Dr. Chen participates in several integrated research programs and serves as an investigator for translational application of omics studies.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords